Live feed
·
INSIDERFiling
Supernus Pharmaceuticals Inc. logo

SVP, Chief Tech. Ops. Officer Mottola Frank converted options into 3,750 shares, covered exercise/tax liability with 1,793 shares and sold $87,074 worth of shares (1,623 units at $53.65), increasing direct ownership by 2% to 18,440 units (SEC Form 4)